212 related articles for article (PubMed ID: 35589251)
1. Haemostatic alterations and management of haemostasis in patients with cirrhosis.
Lisman T; Caldwell SH; Intagliata NM
J Hepatol; 2022 Jun; 76(6):1291-1305. PubMed ID: 35589251
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology and management of bleeding and thrombosis in patients with liver disease.
van den Boom BP; Lisman T
Int J Lab Hematol; 2022 Sep; 44 Suppl 1(Suppl 1):79-88. PubMed ID: 35446468
[TBL] [Abstract][Full Text] [Related]
3. Treatment of bleeding in patients with liver disease.
Northup PG; Lisman T; Roberts LN
J Thromb Haemost; 2021 Jul; 19(7):1644-1652. PubMed ID: 33974330
[TBL] [Abstract][Full Text] [Related]
4. Rotational ThromboElastometry-guided blood component administration versus standard of care in patients with Cirrhosis and coagulopathy undergoing Invasive ProcEdures (RECIPE): study protocol for a randomised controlled trial.
Janko N; Majeed A; Kemp W; Hogan C; Nandurkar H; Roberts SK
Trials; 2023 Aug; 24(1):516. PubMed ID: 37568228
[TBL] [Abstract][Full Text] [Related]
5. Haemostasis in cirrhosis: Understanding destabilising factors during acute decompensation.
Zanetto A; Northup P; Roberts L; Senzolo M
J Hepatol; 2023 May; 78(5):1037-1047. PubMed ID: 36708812
[TBL] [Abstract][Full Text] [Related]
6. AGA Clinical Practice Update: Coagulation in Cirrhosis.
O'Leary JG; Greenberg CS; Patton HM; Caldwell SH
Gastroenterology; 2019 Jul; 157(1):34-43.e1. PubMed ID: 30986390
[TBL] [Abstract][Full Text] [Related]
7. In vitro efficacy of pro- and anticoagulant strategies in compensated and acutely ill patients with cirrhosis.
Lisman T; Kleiss S; Patel VC; Fisher C; Adelmeijer J; Bos S; Singanayagam A; Stoy SH; Shawcross DL; Bernal W
Liver Int; 2018 Nov; 38(11):1988-1996. PubMed ID: 29768734
[TBL] [Abstract][Full Text] [Related]
8. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
Violi F; Basili S; Raparelli V; Chowdary P; Gatt A; Burroughs AK
J Hepatol; 2011 Dec; 55(6):1415-27. PubMed ID: 21718668
[TBL] [Abstract][Full Text] [Related]
9. Management of haemostatic alterations and associated disorders in cirrhosis in Spain: A national survey.
Fortea JI; Puente Á; Ezcurra I; Cuadrado A; Arias-Loste MT; Cabezas J; Llerena S; Iruzubieta P; Rodríguez-Lope C; Huelin P; Casafont F; Fábrega E; Crespo J
Dig Liver Dis; 2019 Jan; 51(1):95-103. PubMed ID: 29960901
[TBL] [Abstract][Full Text] [Related]
10. Haemostatic Profiles are Similar across All Aetiologies of Cirrhosis.
Bos S; van den Boom B; Kamphuisen PW; Adelmeijer J; Blokzijl H; Schreuder T; Lisman T
Thromb Haemost; 2019 Feb; 119(2):246-253. PubMed ID: 30609442
[TBL] [Abstract][Full Text] [Related]
11. [Liver cirrhosis--procoagulant stasis].
Prelipcean CC; Fierbinteanu-Braticevici C; Drug VL; Lăcătuşu C; Mihai B; Mihai C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):678-85. PubMed ID: 22046771
[TBL] [Abstract][Full Text] [Related]
12. Cirrhotic coagulopathy: A rebalanced hemostasis.
Singh AD; Mucha SR; Lindenmeyer CC
Cleve Clin J Med; 2022 Sep; 89(9):523-533. PubMed ID: 37907441
[TBL] [Abstract][Full Text] [Related]
13. The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease.
Lisman T; Hernandez-Gea V; Magnusson M; Roberts L; Stanworth S; Thachil J; Tripodi A
J Thromb Haemost; 2021 Apr; 19(4):1116-1122. PubMed ID: 33792172
[TBL] [Abstract][Full Text] [Related]
14. Hemostasis in liver transplantation: Pathophysiology, monitoring, and treatment.
Hartmann M; Szalai C; Saner FH
World J Gastroenterol; 2016 Jan; 22(4):1541-50. PubMed ID: 26819521
[TBL] [Abstract][Full Text] [Related]
15. Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: Effect on conventional coagulation tests and thrombomodulin-modified thrombin generation.
Rassi AB; d'Amico EA; Tripodi A; da Rocha TRF; Migita BY; Ferreira CM; Carrilho FJ; Farias AQ
J Hepatol; 2020 Jan; 72(1):85-94. PubMed ID: 31536747
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulation in cirrhosis: a new paradigm?
Leonardi F; Maria N; Villa E
Clin Mol Hepatol; 2017 Mar; 23(1):13-21. PubMed ID: 28288507
[TBL] [Abstract][Full Text] [Related]
17. EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis.
;
J Hepatol; 2022 May; 76(5):1151-1184. PubMed ID: 35300861
[TBL] [Abstract][Full Text] [Related]
18. How to assess hemostasis in patients with severe liver disease.
Lisman T
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):267-273. PubMed ID: 38066858
[TBL] [Abstract][Full Text] [Related]
19. Rational hemostatic management in cirrhosis: from old paradigms to new clinical challenges.
La Mura V; Bitto N; Tripodi A
Expert Rev Hematol; 2022 Dec; 15(12):1031-1044. PubMed ID: 36342412
[TBL] [Abstract][Full Text] [Related]
20. Bleeding Risk with Invasive Procedures in Patients with Cirrhosis and Coagulopathy.
Zakeri N; Tsochatzis EA
Curr Gastroenterol Rep; 2017 Sep; 19(9):45. PubMed ID: 28752476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
